The following is a summary of the NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript:

Financial Performance:

• For Q4 2024 NeueHealth posted a revenue of $232.6 million, and full year revenue reached $936.7 million.

• Gross margin for the fourth quarter was reported at $47.7 million and $194.5 million for the entire year.

• The company achieved adjusted EBITDA of $5.5 million in Q4 and $22.5 million for the full year.

Business Progress:

• The company expanded its consumer base significantly to 483,000 consumers by the end of 2024, achieving a compound annual growth rate of 123% since 2020.

• Successfully entered definitive agreement to be acquired by an affiliate of one of its largest investors, NEA, aiming for completion in Q2 of 2025.

• Expanded into new markets and secured new payer partnerships, specifically in MSSP and other product verticals.

Opportunities:

• The strategic expansion into new geographies and demographic segments in 2025 presents an opportunity for further growth.

• Existing and new payer partnerships offer opportunities to deepen market penetration.

Risks:

• While transitioning to a private entity under the acquisition by NEA, operational and strategic adjustments could pose risks affecting performance.

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.